AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Telix Submits Pixclara to FDA for Review
August 28, 2024 06:02 PM AEST| By Team Kalkine MediaTelix Pharmaceuticals,(ASX: TLX),has made significant progress in its efforts to enhance brain cancer diagnostics. The company recently filed a New Drug Application (NDA) with the US Food and Drug Administration (FDA) for TLX101-CDx (Pixclara), an in...
Pacific Smiles Sees Strong Start to FY2025 with 10.9% Increase in Patient Fees
August 28, 2024 10:05 AM AEST| By Team Kalkine MediaPacific Smiles Group (ASX: PSQ) has reported a promising start to the 2024-25 financial year, with patient fees rising by 10.9% to $50.8 million in the first two months. This positive momentum reflects the company’s efforts to enhance the utilization...
Nanosonics (ASX:NAN) Shares Surge 11.85% on FY24 Results
August 27, 2024 05:17 PM AEST| By Team Kalkine MediaNanosonics Ltd (ASX:NAN) saw a significant boost in its share price on Tuesday, rising 11.85% to AU$3.02 following the release of its full-year FY24 results. The stock, which opened at AU$2.86, climbed to an intraday high of AU$3.08 as investors reac...
Actinogen Medical's (ASX:ACW) sharer price jumps 463% in 5 years, drops 47% in a month
August 27, 2024 05:01 PM AEST| By Team Kalkine MediaActinogen Medical Limited (ASX:ACW) has seen a sharp 47% decline in its share price over the past month, leaving shareholders concerned about the short-term outlook. However, when viewed over a more extended period, the company’s performance remains...
Tryptamine Therapeutics (ASX:TTM) Completes First-Ever IV Psilocin Injections to Set Safety Baseline
August 26, 2024 12:17 PM AEST| By Team Kalkine MediaHeadlines:,Completion of Initial Study:,Tryptamine Therapeutics (ASX:TYP) has finalized its first intravenous (IV) psilocin injection study with 11 patients, focusing on establishing baseline safety data.,Safety and Dosage Focus:,The study, involving...
Actinogen's Xanamem Shows Notable Advances with Four-Week 10mg Daily Regimen
August 26, 2024 11:27 AM AEST| By Team Kalkine MediaHeadlines,Promising Results for Xanamem:,Actinogen’s novel antidepressant, Xanamem, has shown significant efficacy in treating major depression with a daily 10mg dose, leading to a 30% increase in the company's share price.,Unique Mechanism of Action...
Fisher & Paykel (ASX: FPH) Updates Profit Forecast for FY25
August 23, 2024 10:34 AM AEST| By Team Kalkine MediaFisher & Paykel Healthcare Corporation Ltd (ASX: FPH) has revised its profit forecast for the fiscal year 2025, anticipating a net profit after tax (NPAT) of between $320 million and $370 million. This forecast represents an increase from the previou...
Clarity Pharmaceuticals and Next Science: Key Updates in the Biotech Sector
August 22, 2024 06:25 PM AEST| By Team Kalkine MediaClarity Pharmaceuticals,(ASX: CU6),has received a significant boost with the FDA granting 'Fast Track' designation to its new imaging agent, 64Cu-SAR-bisPSMA, designed for detecting prostate cancer. This designation is set to accelerate the developme...
US FDA Grants Fast Track Status to Clarity Pharma’s (ASX:CU6) Innovative Prostate Cancer PET Imaging Compound
August 22, 2024 11:57 AM AEST| By Team Kalkine MediaHighlights:,FDA Fast Track Status,:,Clarity Pharmaceuticals has received fast track status from the US FDA for its prostate cancer imaging compound, 64Cu-SAR-bisPSMA, which is designed for PET scans.,Accelerated Approval,:,The,fast track,designation...
Osteopore (ASX:OSX) Completes 3D-Printed Bone Implant Study Funded by Chilean Government
August 22, 2024 10:30 AM AEST| By Team Kalkine MediaOsteopore Limited (ASX:OSX),has successfully concluded a research program funded by the Chilean government, focused on developing a 3D-printed bone implant designed to enhance regenerative healing. This research marks a significant milestone for the...
Healius Ltd (ASX:HLS) Shares Surge 9% After Full-Year Results Amidst ASX 200 Decline
August 21, 2024 02:57 PM AEST| By Team Kalkine MediaHealius Ltd (ASX:HLS), a prominent player in the pathology and imaging sector, is enjoying a notable boost in its share price today. While the S&P/ASX 200 Index (ASX: XJO) has dipped by 0.5%, Healius shares have surged by 8.8%, climbing to AU$1.60 fr...
EBOS Group (ASX:EBO)Sees Bright Future Despite Recent Setbacks
August 21, 2024 11:48 AM AEST| By Team Kalkine MediaEBO.AX: EBOS Group (ASX:EBO), the New Zealand-based healthcare and pet products company, is moving forward with renewed confidence after a successful year. Despite a failed attempt to acquire Greencross in late 2023, EBOS has reported record sales an...
Healius Suspends Dividend Amid Increased Losses
August 21, 2024 11:02 AM AEST| By Team Kalkine MediaHealius Ltd, a prominent,ASX healthcare stock,in the Australian pathology sector, has recently released its financial results for the fiscal year 2024 (FY24), revealing a challenging year marked by deepened losses. Despite a modest increase in revenu...
INOVIQ (ASX:IIQ) Announces Blood Test for Parkinson’s Disease, Building on Alzheimer’s Success
August 20, 2024 11:27 AM AEST| By Team Kalkine MediaINOVIQ (ASX:IIQ) saw its shares rise by 6% on Tuesday following the company’s announcement of a breakthrough in blood testing for Parkinson’s Disease (PD). This new development comes on the heels of a similar success with Alzheimer’s Disease (AD) rep...
ASX Health Stocks: LTR Pharma’s ED Therapy Advances Under TGA Scheme
August 16, 2024 05:26 PM AEST| By Team Kalkine MediaLTR Pharma Ltd (ASX:LTP) has reached a significant milestone in the launch of its nasal spray treatment for erectile dysfunction (ED), with the first select group of patients receiving Spontan under the Therapeutic Goods Administration (TGA) Authoris...
Cochlear Ltd (ASX: COH) Faces Share Price Drop Despite Positive Results
August 16, 2024 01:47 PM AEST| By Team Kalkine MediaCochlear Ltd, a prominent player in the hearing implant sector, saw its share price fall by 7% following the release of its financial results for the fiscal year 2024 (FY24). Despite reporting robust financial and operational performance for the year...
Wellnex (ASX:WNX) Announces First Special Access Scheme Prescriptions for New Wellness Life Brand
August 16, 2024 10:09 AM AEST| By Team Kalkine MediaWellnex (ASX:WNX) has reached a significant milestone with the launch of its Wellness Life brand, now available through the Therapeutic Goods Administration's (TGA) Special Access Scheme (SAS). This marks the first set of prescriptions for Wellness L...
Cochlear (ASX:COH) Shares Dive After Disappointing Profit Forecast
August 15, 2024 12:26 PM AEST| By Team Kalkine MediaShares in Cochlear (ASX:COH) plummeted over 8% on Thursday after the Australian hearing implants maker revealed a profit forecast for the current fiscal year that fell short of market expectations. This unexpected forecast prompted a sharp sell-off,...
Pro Medicus Ltd (ASX: PME) Share Price Soars After Impressive FY24 Results
August 14, 2024 04:59 PM AEST| By Team Kalkine MediaPro Medicus Ltd,(ASX: PME),is enjoying a notable boost in its share price, which has risen by 8% following the release of its robust FY24 financial results. The company, renowned for its expertise in healthcare informatics, offers a comprehensive sui...
Immutep (ASX: IMM) Doses First Human Patient with IMP761 – Potential Broad-Spectrum Autoimmune Treatment
August 14, 2024 10:33 AM AEST| By Team Kalkine MediaHighlights:,First,Human Dosing of IMP761,:,Immutep,(ASX: IMM) has,initiated,its first human trial for IMP761, a new autoimmune treatment based on LAG-3, aiming to modulate malfunctioning T cells associated with autoimmune diseases.,Targeted,Autoimmun...
Advertise your brand on Kalkine Media